icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
Lung Function Decline in HIV: Effects of Immediate vs. Deferred ART Treatment on Lung Function Decline in a Multi-site, International, Randomized Controlled Trial - START
 
 
  Reported by Jules Levin
 
EACS 2015 Oct 21-25 Barcelona, Spain - 15th European AIDS Conference
 
Ken Kunisaki, Dennis Niewoehner, Gary Collins, Daniel Nixon, Ellen Tedaldi, Christopher Akolo, Cissy Kityo, Hartwig Klinker, Alberto La Rosa, Jørgen Vestbo, John Connett for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Pulmonary Substudy Group
 
EACS: No Difference between the Effects of Immediate versus Deferred ART on Neuropsychological Test Performance in HIV-Positive Adults with CD4+ Cell Counts > 500 cells/μL (10/27/15) from Jules: bear in mind the deferred patient group likely had relatively high CD4 compared to patients with lower nadir CD4 like around 100 or even as much as 200-250, where you would be more likely to see a decline in cognitive function, either symptomatic or asymptomatic. As well, look at the background characteristics for the study patients and you will see "low substance abuse and hepatitis" and low psychiatric disease, and they call the groups "medically well, early HIV infection".
 
IWCADRH: Effects of immediate versus deferred initiation of antiretroviral therapy on bone mineral density: a substudyof the INSIGHT Strategic Timing of Antiretroviral Therapy (START) study - (10/23/15)

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif

EACS11.gif

EACS12.gif

EACS13.gif

EACS14.gif

EACS15.gif

EACS16.gif

EACS17.gif

EACS18.gif